Autologous platelet rich plasma in pyoderma gangrenosum - two case reports.

Indian J Dermatol

Department of Dermatology, Sexually Transmitted Disease and Leprosy, Bangalore Medical College and Research Institute, Bangalore, Karnataka, India. E-mail:

Published: March 2015


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372924PMC
http://dx.doi.org/10.4103/0019-5154.152539DOI Listing

Publication Analysis

Top Keywords

autologous platelet
4
platelet rich
4
rich plasma
4
plasma pyoderma
4
pyoderma gangrenosum
4
gangrenosum case
4
case reports
4
autologous
1
rich
1
plasma
1

Similar Publications

Background: Pilonidal sinus disease (PSD) is a common condition in adolescents, often resulting in recurrence, prolonged recovery, and significant discomfort. Although multiple surgical approaches exist, the optimal treatment for pediatric patients remains unclear. This study aimed to compare the short-term outcomes of endoscopic pilonidal sinus treatment combined with platelet-rich plasma application (EPSIT+PRP) and excision with primary closure (EPC) in children and adolescents with PSD.

View Article and Find Full Text PDF

Platelet-Rich Fibrin (PRF) is an autologous matrix rich in platelets, leukocytes, and growth factors that support tissue regeneration. Enhancing its structural and biological properties through biomaterial supplementation may improve clinical outcomes. This study evaluated the effects of adding hyaluronic acid (HA) and collagen to PRF on growth factor release and mechanical strength.

View Article and Find Full Text PDF

Objective: To identify distinct phenotypes of acute respiratory distress syndrome (ARDS) developing after hematopoietic cell transplantation (HCT), using routinely available clinical data at ICU admission.

Design: Multicenter retrospective cohort study using latent class analysis.

Setting: ICUs across three Mayo Clinic campuses (Minnesota, Florida, and Arizona).

View Article and Find Full Text PDF

Objective: A subset of patients with multiple myeloma (MM) experience early relapse despite the absence of any high-risk features at diagnosis, defined as functional high-risk (FHR) MM with inferior prognosis. This study compared FHR and standard risk (SR) MM cohorts to investigate clinical risk factors and establish a validated prognostic model for early prediction of FHR in patients with MM that were transplanted.

Methods: A retrospective cohort study was conducted to analyze the clinical data of patients with MM.

View Article and Find Full Text PDF

Daratumumab combined with bortezomib, thalidomide, and dexamethasone (Dara-VTD) is a highly effective induction therapy for newly diagnosed multiple myeloma (NDMM) patients eligible for autologous stem cell transplantation (ASCT). However, its impact on stem cell mobilization requires a critical evaluation. This study examines the effects of Dara-VTD on stem cell mobilization and collection outcomes.

View Article and Find Full Text PDF